Antimicrobial activity of ceftolozane/tazobactam tested against contemporary (2015–2017) Pseudomonas aeruginosa isolates from a global surveillance programme-Reference-Cited by-同舟云学术

Antimicrobial activity of ceftolozane/tazobactam tested against contemporary (2015–2017) Pseudomonas aeruginosa isolates from a global surveillance programme

Published:2020-06 Issue: Volume:21 Page:60-64
ISSN:2213-7165
Container-title:Journal of Global Antimicrobial Resistance
language:en
Short-container-title:Journal of Global Antimicrobial Resistance

Author:

Shortridge Dee,Pfaller Michael A.,Streit Jennifer M.,Flamm Robert K.

Funder

Merck & Co., Inc. (Kenilworth, NJ, USA).

Publisher

Elsevier BV

Subject

Microbiology (medical),Immunology,Immunology and Allergy,Microbiology

Reference16 articles.

1. Multistate point-prevalence survey of health care—associated infections;Magill;N Engl J Med,2014

2. Pseudomonas aeruginosaEpidemiology and carbapenem resistance mechanisms of carbapenem-non-susceptible collected during 2009–11 in 14 European and Mediterranean countries;Castanheira;J Antimicrob Chemother,2014

3. Epidemiology of antibiotic resistance in Pseudomonas aeruginosa. Implications for empiric and definitive therapy;Ruiz-Garbajosa;Rev Esp Quimioter,2017

4. Therapies for multidrug resistant and extensively drug-resistant non-fermenting gram-negative bacteria causing nosocomial infections: a perilous journey toward “molecularly targeted” therapy;El Chakhtoura;Expert Rev Anti Infect Ther,2018

5. Pseudomonas aeruginosaAntimicrobial activity of ceftolozane/tazobactam tested against and Enterobacteriaceae with various resistance patterns isolated in European hospitals (2011–12);Sader;J Antimicrob Chemother,2014

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring the World of ß-Lactamase Inhibitors;Advances in Medical Technologies and Clinical Practice;2024-04-01

2. Activity of ceftolozane/tazobactam, imipenem/relebactam and ceftazidime/avibactam against clinical Gram-negative isolates—SMART United States 2019–21;JAC-Antimicrobial Resistance;2023-12-28

3. Pharmacokinetic and Pharmacodynamic Considerations of Novel Antibiotic Agents for Pediatric Infections: A Narrative Review;Surgical Infections;2023-10-01

4. Novel Beta Lactam Antibiotics for the Treatment of Multidrug-Resistant Gram-Negative Infections in Children: A Narrative Review;Microorganisms;2023-07-13

5. Comparison of In Vitro Activity of Ceftazidime-Avibactam and Imipenem-Relebactam against Clinical Isolates of Pseudomonas aeruginosa;Microbiology Spectrum;2023-06-15